BioRestorative Therapies, Inc. - Common Stock (BRTX)
0.2695
-0.0005 (-0.19%)
NASDAQ · Last Trade: Feb 25th, 4:41 AM EST
Detailed Quote
Previous Close
0.2700
Open
-
Bid
0.2500
Ask
0.2518
Day's Range
N/A - N/A
52 Week Range
0.1900 - 2.280
Volume
93,615
Market Cap
2.39M
PE Ratio (TTM)
-0.1833
EPS (TTM)
-1.5
Dividend & Yield
N/A (N/A)
1 Month Average Volume
14,759,997
Chart
About BioRestorative Therapies, Inc. - Common Stock (BRTX)
Biorestorative Therapies Inc is a biotechnology company focused on developing innovative solutions for regenerative medicine, particularly in the areas of musculoskeletal and metabolic diseases. The company is engaged in researching and commercializing therapeutic products using advanced cellular technologies, including adult stem cells. Biorestorative Therapies aims to create treatments that enhance the body's natural healing processes, with a commitment to addressing unmet medical needs and improving patient outcomes through its proprietary methods and therapies. Read More
DETROIT, MICHIGAN - July 16, 2025 ( NEWMEDIAWIRE ) - Lance Alstodt, CEO of BioRestorative Therapies (NASDAQ: BRTX), was recently a guest on Benzinga’s All-Access.
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based
BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical-stage regenerative medicine company developing stem cell-based
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based
